Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 3 3Phase 2 2Phase 2/3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1278Carcinoma, Non-Small-Cell Lung 927Prostatic Neoplasms 729Neoplasms 633Multiple Myeloma 554Lymphoma 540Colorectal Neoplasms 530Lung Neoplasms 515Leukemia 498Leukemia, Myeloid, Acute 474Neoplasm Metastasis 471Melanoma 426Lymphoma, Non-Hodgkin 420Ovarian Neoplasms 417Leukemia, Lymphocytic, Chronic, B-Cell 386Pancreatic Neoplasms 373Recurrence 338Precursor Cell Lymphoblastic Leukemia-Lymphoma 329Head and Neck Neoplasms 307Lymphoma, Large B-Cell, Diffuse 295Glioblastoma 294Myelodysplastic Syndromes 288Lymphoma, Follicular 287Brain Neoplasms 287Stomach Neoplasms 282Carcinoma, Renal Cell 268Carcinoma, Hepatocellular 262Hodgkin Disease 261Rectal Neoplasms 256Sarcoma 250

Interventions

liposomal doxorubicin 1Mass Screening 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Heart Diseases × Clear all
NCT01714271 2023-10-02

Promotora-based Latino Family CVD Risk Reduction

University of California, Los Angeles

Phase 2 Completed
204 enrolled

Heart Diseases, Neoplasms

NCT00563953 2017-10-12

CAPRICE

SOLTI Breast Cancer Research Group

Phase 2 Completed
50 enrolled
Breast

Breast Neoplasms, Heart Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡